Novartis Should Pay $285 Million in Gender Lawsuit, Bias Lawyer Says

May 19, 2010

Related

Celltrion to buy US biologics manufacturing plant as part of tariff response strategy

Celltrion to buy US biologics manufacturing plant as part of tariff response strategy

‘Cobots’ drive pharma’s shift toward scalable cell therapies

‘Cobots’ drive pharma’s shift toward scalable cell therapies

OnTrak Wireless: Total Bearing Health Solution

Sponsored

OnTrak Wireless: Total Bearing Health Solution

OnTrak Wireless & UltraTrak Vario Lubricators: Bearing Health Unified

Sponsored

OnTrak Wireless & UltraTrak Vario Lubricators: Bearing Health Unified

Trending

Biopharma’s manufacturing agility wanes amid supply chain resilience: survey

Lonza confirms full-year 2025 outlook for CDMO business amid geopolitical uncertainty

Editor’s (re)View: Novo Nordisk knew what it was getting in purchase of troubled Indiana site

Sponsored Picks

Sponsored

OnTrak Wireless & UltraTrak Vario Lubricators: Bearing Health Unified

Sponsored

OnTrak Wireless: Total Bearing Health Solution

Sponsored

Early Intervention with OnTrak Wireless for High-Heat Environments